{
  "pmcid": "10364515",
  "sha256": "a80ac88bbfa59dcf47695218f8fad1cdf1da42aaedf34bc11874728432d0779c",
  "timestamp_utc": "2025-11-09T15:06:54.567493+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.623673954372624,
    "reading_ease": 38.4141928073511,
    "word_count": 263
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A multicentre, non-inferiority RCT was conducted"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomized to receive SAP or TAP."
      },
      "Participants": {
        "score": 2,
        "evidence": "patients with an incompetent great saphenous vein or anterior accessory saphenous vein with one or more incompetent tributaries."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomized to receive SAP or TAP."
      },
      "Objective": {
        "score": 1,
        "evidence": "The aim of this study was to determine whether single ambulatory phlebectomy with or without delayed endovenous truncal ablation (SAP) is non-inferior to thermal endovenous ablation with concomitant phlebectomy (TAP), and whether SAP is a cost-effective alternative to TAP."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was VEnous INsufficiency Epidemiological and Economic Study Quality of Life/Symptoms (VEINES-QOL/Sym score) after 12 months."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Participants were randomized to receive SAP or TAP."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Some 464 patients received the allocated treatment (SAP 227, TAP 237)."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "VEINES-QOL scores were 52.7 (95 per cent c.i. 51.9 to 53.9) for SAP and 53.8 (53.3 to 55.1) for TAP; VEINES-Sym scores were 53.5 (52.6 to 54.4) and 54.2 (54.0 to 55.6) respectively."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Registration number: NTR 4821 ( www.trialregister.nl )."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 15,
    "max_score": 25
  }
}